Neuzillet, Cindy, 1984-....
![Sudoc [ABES], France](/viaf/images/flags/SUDOC.png "Sudoc [ABES], France")
Cindy Neuzillet
Neuzillet, Cindy
VIAF ID: 306319251 ( Personal )
Permalink: http://viaf.org/viaf/306319251
Preferred Forms
-
100 0 _
‡a
Cindy Neuzillet
-
200 _ |
‡a
Neuzillet
‡b
Cindy
-
100 1 _
‡a
Neuzillet, Cindy
-
100 1 _
‡a
Neuzillet, Cindy,
‡d
1984-....
4xx's: Alternate Name Forms (2)
Works
| Title | Sources |
|---|---|
| Autoimmune pancreatitis with atypical imaging findings that mimicked an endocrine tumor |
|
| Difficult Diagnosis of Atypical Cystic Pancreatic Lesions in von Hippel-Lindau Disease |
|
| Digestive System Mixed Neuroendocrine-Non-Neuroendocrine Neoplasms. |
|
| Disease control with sunitinib in advanced intrahepatic cholangiocarcinoma resistant to gemcitabine-oxaliplatin chemotherapy. |
|
| The early diagnosis of colorectal and pancreatic cancers. |
|
| Efficacy of a sequential treatment strategy with GEMOX-based followed by FOLFIRI-based chemotherapy in advanced biliary tract cancers. |
|
| Elaborating novel and effective treatment for pancreatic cancer |
|
| Élaboration d'un nouveau traitement efficace contre le cancer du pancréas. |
|
| Évaluation in vitro et in vivo de deux nouvelles stratégies thérapeutiques ciblées dans l'adénocarcinome pancréatique : une immunothérapie ciblant l'Immune Checkpoint Galectine-9 et une thérapie photodynamique ciblant le récepteur folate |
|
| Everolimus affects vasculogenic mimicry in renal carcinoma resistant to sunitinib. |
|
| Fluropyrimidine single agent or doublet chemotherapy as second line treatment in advanced biliary tract cancer |
|
| FOLFIRI regimen in metastatic pancreatic adenocarcinoma resistant to gemcitabine and platinum-salts |
|
| Hépato-gastroentérologie |
|
| High c-Met expression in stage I-II pancreatic adenocarcinoma: proposal for an immunostaining scoring method and correlation with poor prognosis. |
|
| Ictus amnésique induit par des explorations fonctionnelles de l’œsophage |
|
| Impact du dialogue entre microenvironnement et cellules cancéreuses dans l'adénocarcinome canalaire pancréatique |
|
| Impact of crosstalk between microenvironment and cancer cells in pancreatic ductal adenocarcinoma. |
|
| Inter- and intra-tumoral heterogeneity and dynamics of cancer-associated fibroblasts in pancreatic ductal adenocarcinoma |
|
| Is primary tumor resection associated with a longer survival in colon cancer and unresectable synchronous metastases? A 4-year multicentre experience |
|
| [Medical management of cholangiocarcinomas in 2015]. |
|
| MEK in cancer and cancer therapy |
|
| Modulation of collagen and MMP-1 gene expression in fibroblasts by the immunosuppressive drug rapamycin. A direct role as an antifibrotic agent? |
|
| New treatment options with cytotoxic agents in neuroendocrine tumours. |
|
| De novo cancer after solid organ transplantation: Epidemiology, prognosis and management |
|
| Nutrition and physical activity: French intergroup clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, AFC, SFP-APA, SFNCM, AFSOS) |
|
| Oncogenic functions of the cytosolic phospholipase A2 alpha during pancreatic tumoral progression. |
|
| Polymerase proofreading domain mutations: New opportunities for immunotherapy in hypermutated colorectal cancer beyond MMR deficiency |
|
| Rationale and design of the Adapted Physical Activity in advanced Pancreatic Cancer patients (APACaP) GERCOR (Groupe Coopérateur Multidisciplinaire en Oncologie) trial: study protocol for a randomized controlled trial |
|
| Récidive tumorale précoce après résection d'un cancer du pancréas : la voie de HGF/c-Met et l’hypoxie tumorale sont-elles des facteurs pronostiques majeurs ? |
|
| Resistance to targeted therapies in pancreatic neuroendocrine tumors (PNETs): molecular basis, preclinical data, and counteracting strategies |
|
| The role of cytidine deaminase in the control of replicative stress and resistance of pancreatic cancer cells to DNA-targeting agents. |
|
| Severe hyponatremia caused by nab-paclitaxel-induced syndrome of inappropriate antidiuretic hormone secretion: A case report in a patient with metastatic pancreatic adenocarcinoma |
|
| State of the art and future directions of pancreatic ductal adenocarcinoma therapy |
|
| Syndrome de Verner-Morrison révélant un ganglioneuroblastome chez un adulte |
|
| Targeting the Ras-ERK pathway in pancreatic adenocarcinoma. |
|
| Targeting the TGFβ pathway for cancer therapy. |
|
| Tumeur desmoplastique à petites cellules rondes du pancréas avec métastase mammaire |
|
| Unravelling the pharmacologic opportunities and future directions for targeted therapies in gastro-intestinal cancers part 2: Neuroendocrine tumours, hepatocellular carcinoma, and gastro-intestinal stromal tumours. |
|
| Utilisation des gènes de glycosyltransférases pour stratifier les patients atteints d'adénocarcinome pancréatique : identification d'une glyco-signature pronostique et biomarqueurs associés |
|
